CHELI, STEFANIA

CHELI, STEFANIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping 2023 Cheli, StefaniaClementi, Emilio + Article (author) -
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5 2021 Cheli S.Fusi M.De Silvestri A.Clementi E.Cattaneo D.Baldelli S. + Article (author) -
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 2021 Cheli S.Baldelli S.Fusi M.Cattaneo D.Clementi E. + Article (author) -
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients 2021 Casazza G.Cheli S.Dalu D.Fasola C.Filipazzi V.Clementi E. + Article (author) -
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 2019 CORTI, SILVIAPaola PileriMartina I. MazzoccoChiara MandòAnna F. MoscatielloDario CattaneoStefania CheliSara BaldelliEmilio ClementiIrene Cetin + Article (author) -
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? 2019 Nichetti, FedericoFalvella, Felicia StefaniaCheli, StefaniaFucà, GiovanniInfante, Gabrielede Braud, FilippoPietrantonio, Filippo + Article (author) -
Different effects of glucocorticoids on darunavir plasma concentrations 2019 Cattaneo, DarioCheli, StefaniaFusi, MartaClementi, Emilio + Article (author) -
Clinical and genetic determinants of nevirapine plasma trough concentration 2018 Giacomelli, AndreaRusconi, StefanoCozzi, ValeriaMonge, ElisaCheli, StefaniaClementi, EmilioRiva, AgostinoGalli, Massimo + Article (author) -
HLA-B*57: 01 testing : Care in interpreting the quality of different genotyping methods 2017 F.S. FalvellaS. CheliE. Clementi Article (author) -
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression : a case report 2017 S. AntoniazziM. CigliobiancoD. CattaneoS. CheliE. Clementi + Article (author) -
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting 2017 F.S. FalvellaD. CattaneoC. MazzaliRONZI, PAOLAF. BindaS. CheliS. Antinori + Article (author) -
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab 2016 S. CheliG. InfanteF. de BraudE. ClementiF. Pietrantonio + Article (author) -
The role of Toll-like receptor 4 polymorphisms in vaccine immune response 2016 P. PellegrinoF.S. FalvellaS. CheliC. PerrottaE. ClementiS. Radice Article (author) -
Pharmacogenetic approach to losartan in Marfan patients : A starting point to improve dosing regimen? 2016 S. CheliS. MontanelliA. FerraraE. Clementi + Article (author) -
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir 2015 A.M. PeriC. MazzaliE. CalviE. ClementiS. CheliS. AntinoriF.S. Falvella + Article (author) -
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors 2015 A. LombardiS. CheliC. MazzaliE. ClementiF.S. Falvella + Article (author) -
LightSNiP assay is a good strategy for pharmacogenetics test 2015 S. CheliF. PietrantonioE. Clementi + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 2015 F.S. FalvellaS. CheliC. MaggiM. NigerF. RicchiniI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 2013 D. CattaneoF.S. FalvellaP. VitielloS. CheliE. ClementiA. Riva + Article (author) -